PFSA Profusa Inc.

$PFSA - this is too cheap and quite possibly the most ideal share structure in the market. There could be BIG news at any time 💡 ▪️Already pre-selling in Europe for launch. ▪️$1.5M - $3M revenue guidance for 2026 from European pre-sales. ▪️Major hurdle passed in September. Undergoing final review for CE trademark. ▪️Acquiring a diagnostics company that made $111M in 2025 (no DA yet) Too much going on to be a sub-$1M MC bio.

🚀🔥 * $PFSA *– NEXT BIG MOVE?** 🧬 Profusa's biosensor technology continues advancing! ✅ ISO 13485:2016 certification strengthens its quality management credentials. 🔥 **POTENTIAL CATALYSTS:** 🚀 G3 Vision Labs acquisition updates 🚀 Lumee regulatory progress 🚀 New partnerships and commercialization 🚀 Renewed buying volume 💥 **PAST SPIKES:** PFSA has a history of explosive moves! Positive news and strong volume could trigger another momentum run! ⚠️ Dilution and Nasdaq compliance risks remain. **Do your own DD.**

$PFSA set those cell orders, nice and high folks so the money makers can’t give them to shorters. There’s a reason why that $27 sell order is on the books. If we all do that together, there could be some nice movement for a potential squeeze with the upcoming merger news.

$PFSA - extremely small nano-float with $10 cash-per-share and upcoming new(s). $RBNE - 10c divvy 💡 $LGHL - smallest non-otc MC on the market (sub-$100k) $LBGJ - asian nano-floater gaining attention. Expecting another PR soon.

🚀* $PFSA *– ANOTHER BIG RUN COMING? 🔥 💥 Yesterday's MASSIVE 44M+ volume has traders watching for continuation! 📈 PAST SPIKES: 🔥 Sept. 24: Hit $4.18 on nearly 79M volume! 🔥 Sept. 29: Gained 34%! 🔥 Oct. 22: Volume exploded nearly 200X! 🚀 UPCOMING POTENTIAL CATALYSTS: ✅ G3 Vision Labs acquisition developments ✅ Lumee Oxygen regulatory progress following ISO certification ✅ Potential CE marking and commercialization ✅ New partnerships, orders and revenue growth 💎 BULLISH SCENARIO: A breakout above $1.10–$1.15 with strong volume could bring $1.33 into focus. PFSA has demonstrated explosive moves before! ⚠️ Dilution and downside risks remain. 🔥 Could yesterday's volume signal another major momentum run? IMHO – DO YOUR OWN DD! 🚀

$PFSA that last 1 min short for 29000 shares just cost the immediate cover at $.75 $1165 OUCH!🔥⬆️👍👌✅ burn the shorts!

🚀🔥 * $PFSA *— NEW SEC FILING!** 💎 Ascent Partners and affiliates disclosed **9.99% beneficial ownership (316,600 shares)** in an October 27 Schedule 13G/A! 📊 50K shares directly held; 266.6K potentially obtainable through financing arrangements. 🔥 **BULLISH POTENTIAL:** ✅ Greater ownership transparency 🚀 History of explosive price spikes 💥 Potential renewed buying momentum 🎯 **UPCOMING CATALYSTS:** 🔹 G3 Vision Labs acquisition updates 🔹 Lumee commercialization progress 🔹 Regulatory and strategic announcements 💎 Trading well below previous spike levels! Positive news could reignite momentum! ⚠️ Ownership disclosure isn't new buying. Dilution remains a risk. 🔥 **$PFSA — ANOTHER RUN BREWING?** 🚀

$PFSA seeing 5000 shares for sale over $27 on level 2. First time I’ve seen that. I wonder if someone knows something?!?. Management?⬆️✅🚀🔥

$PFSA I posted where the entry/support and exit/resistance levels are. The 5 minute chart just flipped bullish, now waiting on algos. $1 is the stop loss as well. No volume, no party

$PFSA Massively accumulating! Just like we did with AMOD right under VWAP, the buying force is huge on historical data that makes the chart dominate any selling pressure. Buys are way over sales and they are accumulated, MM will have to let it go ! 🔥

$PFSA - Should not be under $1. In fact, this should be a few dollars considering the pre-sales and cash-per-share. Do DD. These are on Fire Sale too 💡 $LGHL $GP $SHFS

$PFSA Theres a pattern here! The naked short covers through the day with retail short attempts then shorts it at the oprn every day trying to force it lower. (Shown here on the volume each open) They are trying to cover below $0,85 from $2.50 area

$PFSA .80-.87 price target today lol $$$$$$$$$. Donnie done with LUCD stock for now lmao $$$$$ back to PFSA lol $$$$

$PFSA today range is .83-.90 cents I’m so so sorry I felt bad in my bottom of my heart smh $$ Donnie right again smh 🤦‍♀️. $1.25 short avg :))))))))))))))

$PFSA you must be brainwashed and seduced lmao all you clowns 🤡 LOL $600,000 Market cap = scam ponzi stock !!!!!!!!

$PFSA , ,. Go , Go , go shorty it’s your birthday we gonna party 😂😂😂 yall ok out there is got little to 🥵 for yall ?

$PFSA set your sell limits, high folks. This flat line is a beautiful thing, no more sellers. This thing is going to absolutely rock it on the merger news. I’m talking another 50 million share transaction day. I’m setting my cell limit at around 25 or $27. There are already a few sell blocks around this amount which means something is brewing. So many catalysts upcoming. They’ve already satisfied multiple funding conditions and awaiting the financial statements to complete the merger.

$PFSA Here comes the boom people. Get ready for a quick double up or if it catches fire 10 X increase. Just a few more conditions precedent to satisfy for the upcoming merger. $UVIX $WETO $AMC $GME

📈 Top Penny Stock Movers by Relative Volume $PFSA — 7.30x RVOL Move: +30% Volume: 37.3M (5.1M average) Market Cap: $5.1M Day Range: 0.95 – 1.35 52-Week Range: 0.70 – 3000.00 $FLL — 2.87x RVOL Move: +21% Volume: 780.6K (272.0K average) Market Cap: $42.1M Day Range: 0.98 – 1.18 52-Week Range: 0.92 – 3.37 $SKYQ — 2.85x RVOL Move: +10% Volume: 5.9M (2.1M average) Market Cap: $11.4M Day Range: 2.31 – 2.60 52-Week Range: 1.10 – 19.45 Momentum and unusual volume are driving attention. Which one are you watching? 👀 Not financial advice.

$PFSA next big 10x runner. $PFSA 1. Finalizing the G3 Vision Labs Acquisition Expected Timing: Late 2026 / Early 2027 Profusa signed an option agreement to acquire G3 Vision Labs and its subsidiaries (including Dominion Diagnostics and Acutis Diagnostics). If exercised, this transforms PFSA into a public diagnostics operator with a national network of CLIA-certified labs. • The Impact: G3 generated an estimated $111 million in net revenue in 2025. Fulfilling this deal immediately pivots Profusa away from its status as a zero-revenue company. 2. Commercial Launch of the Lumee® Oxygen Platform (CE Mark) Expected Timing: Progress tracking into late 2026 Profusa has been clearing consecutive regulatory hurdles for its flagship bioengineered tissue sensor, the Lumee Oxygen Platform. • The Milestones: In mid-October 2026, the company successfully received its ISO 13485:2016 Certification from European notified body GMED. $AMC $GME $UVXY $TOPS